Researcher.Life Logo

ACS Nano : Impact Factor & More

eISSN: 1936-086XpISSN: 1936-0851

Aims and Scope of ACS Nano

ACS Nano is a monthly, peer-reviewed, scientific journal, first published in August 2007 by the American Chemical Society. The current editor in chief is Paul S. Weiss (University of California, Los Angeles). The journal publishes original research articles, reviews, perspectives, interviews with distinguished researchers, and views on the future of nanoscience and nanotechnology. Less

Key Metrics

CiteScore
24.3
Eigenfactor
0.1 - 0.5
Impact Factor
15 - 20
Scite Index
0.94 5-Year SI
SJR
Q1Engineering (all)
SNIP
2.48
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on ACS Nano

ACS Nano Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • Inspec Inspec
  • SJR SJR
Overview
Publisher AMER CHEMICAL SOC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2007
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in ACS Nano ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in ACS Nano

Corrigendum to "Accuracy of Site versus Core Laboratory Interpretations of Right Heart Catheterization Hemodynamics" [American Heart Journal:295:107351. AMHJ-D-25-01362 (YMHJ_107351)
  • 1 Aug 2026
  • American heart journal
Immune checkpoint inhibitor-induced myocarditis and outcomes after re-exposure.
  • 1 Aug 2026
  • American heart journal
Patient characteristics and prognostic importance of dialysis in IE-A nationwide study.
  • 1 Aug 2026
  • American heart journal
Optimal antiplatelet strategy in patients with advanced chronic kidney disease undergoing drug-eluting stent implantation: Design and rationale of the randomized ADAPT-CKD trial.
  • 1 Aug 2026
  • American heart journal
Design and rationale of a multicenter paramedic randomized trial of noradrenaline versus adrenaline in the initial management of patients with cardiogenic shock-The PANDA trial.
  • 1 Jul 2026
  • American heart journal
Design and rationale of the Impella®-protected cardiac surgery trial (IMPACT): A multicenter, single-arm pilot study in high-risk cardiac surgery patients.
  • 1 Jul 2026
  • American heart journal
Corrigendum to "Accuracy of Site versus Core Laboratory Interpretations of Right Heart Catheterization Hemodynamics" [American Heart Journal:295:107351. AMHJ-D-25-01362 (YMHJ_107351)
  • 1 Aug 2026
  • American heart journal
Immune checkpoint inhibitor-induced myocarditis and outcomes after re-exposure.
  • 1 Aug 2026
  • American heart journal
Patient characteristics and prognostic importance of dialysis in IE-A nationwide study.
  • 1 Aug 2026
  • American heart journal
Optimal antiplatelet strategy in patients with advanced chronic kidney disease undergoing drug-eluting stent implantation: Design and rationale of the randomized ADAPT-CKD trial.
  • 1 Aug 2026
  • American heart journal
Design and rationale of a multicenter paramedic randomized trial of noradrenaline versus adrenaline in the initial management of patients with cardiogenic shock-The PANDA trial.
  • 1 Jul 2026
  • American heart journal
Design and rationale of the Impella®-protected cardiac surgery trial (IMPACT): A multicenter, single-arm pilot study in high-risk cardiac surgery patients.
  • 1 Jul 2026
  • American heart journal

FAQs on ACS Nano